Cargando…

ORF8/ORF8a: a difference between SARS-CoV-2 and SARS-CoV

ORF8 as an accessory protein of SARS-CoV-2 https://bit.ly/3Gr3OTK

Detalles Bibliográficos
Autor principal:	Zandi, Milad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2022
Materias:	Agora
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671798/ https://www.ncbi.nlm.nih.gov/pubmed/34887330 http://dx.doi.org/10.1183/13993003.02818-2021

Ejemplares similares

ORF8a as a viroporin in SARS-CoV-2 infection?
por: Zandi, Milad
Publicado: (2021)

SARS-CoV-2 ORF8 and SARS-CoV ORF8ab: Genomic Divergence and Functional Convergence
por: Mohammad, Sameer, et al.
Publicado: (2020)

ORF9c and ORF10 as accessory proteins of SARS-CoV-2 in immune evasion
por: Zandi, Milad
Publicado: (2022)

Molecular and Biochemical Characterization of the SARS-CoV Accessory Proteins ORF8a, ORF8b and ORF8ab
por: Keng, Choong-Tat, et al.
Publicado: (2009)

Hyperventilation as one of the mechanisms of persistent dyspnoea in SARS-CoV-2 survivors
por: Motiejunaite, Justina, et al.
Publicado: (2021)

The association between SARS-CoV-2 RT-PCR cycle threshold and mortality in a community cohort
por: Waudby-West, Rupert, et al.
Publicado: (2021)

Impact of the SARS-CoV-2 epidemic on tuberculosis treatment outcome in Northern Italy
por: Magro, Paola, et al.
Publicado: (2020)

Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2
por: Yang, Hai-Jun, et al.
Publicado: (2020)

COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection?
por: McAlinden, Kielan Darcy, et al.
Publicado: (2020)

Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2
por: Du, Rong-Hui, et al.
Publicado: (2020)

Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2
por: Zinzula, Luca
Publicado: (2021)

Immune evasion via SARS-CoV-2 ORF8 protein?
por: Park, Matthew D.
Publicado: (2020)

Evolutionary dynamics of the SARS-CoV-2 ORF8 accessory gene
por: Pereira, Filipe
Publicado: (2020)

Socioeconomic correlates of SARS-CoV-2 and influenza H1N1 outbreaks
por: Kaiser, Jan Christian, et al.
Publicado: (2020)

Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection
por: Frija-Masson, Justine, et al.
Publicado: (2020)

Saliva molecular testing for SARS-CoV-2: simplifying the diagnosis without losing accuracy
por: Saluzzo, Francesca, et al.
Publicado: (2021)

Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights
por: Wark, Peter A.B., et al.
Publicado: (2021)

Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients
por: Yu, Hai-qiong, et al.
Publicado: (2020)

Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection
por: Trinkmann, Frederik, et al.
Publicado: (2021)

SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network
por: van Koningsbruggen-Rietschel, Silke, et al.
Publicado: (2020)

Utility and safety of bronchoscopy during the SARS-CoV-2 outbreak in Italy: a retrospective, multicentre study
por: Mondoni, Michele, et al.
Publicado: (2020)

Venous thromboembolism in SARS-CoV-2 patients: only a problem in ventilated ICU patients, or is there more to it?
por: Criel, Maarten, et al.
Publicado: (2020)

Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8
por: Wu, Xin, et al.
Publicado: (2022)

SARS-CoV-2 ORF8 accessory protein is a virulence factor
por: Bello-Perez, M., et al.
Publicado: (2023)

SARS-CoV-2 infections in people with primary ciliary dyskinesia: neither frequent, nor particularly severe
por: Pedersen, Eva S.L., et al.
Publicado: (2021)

Characteristics and outcomes of health and social care workers testing positive for SARS-CoV-2 in the Tayside region of Scotland
por: Siddiqui, Moneeza K., et al.
Publicado: (2020)

Does chemotherapy reactivate SARS-CoV-2 in cancer patients recovered from prior COVID-19 infection?
por: Bi, Jianping, et al.
Publicado: (2020)

Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?
por: Ndjeka, Norbert, et al.
Publicado: (2020)

Inhaled corticosteroids downregulate SARS-CoV-2-related genes in COPD: results from a randomised controlled trial
por: Milne, Stephen, et al.
Publicado: (2021)

Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects
por: Jacobs, Merel, et al.
Publicado: (2020)

Elevated ACE-2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication
por: Chen, Mengfei, et al.
Publicado: (2020)

A unique view of SARS-CoV-2 through the lens of ORF8 protein
por: Hassan, Sk Sarif, et al.
Publicado: (2021)

The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway
por: Li, Jin-Yan, et al.
Publicado: (2020)

Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences
por: Patel, Sheila K., et al.
Publicado: (2021)

An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2
por: Hassan, Sk. Sarif, et al.
Publicado: (2022)

SARS-CoV-2 variants lacking ORF8 occurred in farmed mink and pangolin
por: Pereira, Filipe
Publicado: (2021)

Structural Analysis of SARS-CoV-2 ORF8 Protein: Pathogenic and Therapeutic Implications
por: Valcarcel, Antonio, et al.
Publicado: (2021)

SARS-CoV-2–encoded ORF8 protein possesses complement inhibitory properties
por: Kumar, Jitendra, et al.
Publicado: (2023)

Head-to-head comparison of SARS-CoV-2 antigen-detecting rapid test with professional-collected nasal versus nasopharyngeal swab
por: Lindner, Andreas K., et al.
Publicado: (2021)

Continuous positive airway pressure to avoid intubation in SARS-CoV-2 pneumonia: a two-period retrospective case-control study
por: Oranger, Mathilde, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m4ov69a98t5116s1m19hls9gla